Canchi pharmaceutical industry fell more than 8% or was affected by the Nimesulide incident today

NetEase Finance February 21 News recently a large pharmacy terminal has begun the next "nimesulide particles." This for the "nimesulide" products sales gross profit of the company's overall gross profit of more than 80% of the Canchi pharmaceutical industry, profitability prospects worry.　　The market shock caused by the adverse events of the fever drug of the children is still continuing. Yesterday, Happy NPC pharmacy general Manager Secretary Yau Wen said, since February 15, the company through the Nanchang headquarters to inform Beijing, Shanghai and other subsidiaries of the quality management, will be the Nimesulide granules all the shelves. "Not only is the Canchi pharmaceutical industry's Rui Zhi Qing, other manufacturers of nimesulide particles have been all off the shelves, and have been linked to return."　　Yao Wen also said that, because the state Drug Administration has not yet announced the "Nimesulide granule" adverse reaction of the findings of the other contains "nimesulide" ingredients of the drug, the company although the implementation of the next frame processing, but has not been linked to return. Kyushu Tong da Pharmacy has also begun to recall the "nimesulide particles." Kyushu Tong da Pharmacy Shanghai Week Medicine store a person in charge said that the drug store has been discontinued "Rui Zhi Qing" nimesulide granules, "Just a few days ago headquarters issued a recall, now no longer external sales."　　The shop chief said.　　At present, although a few pharmacies in Shanghai are still selling "nimesulide granules", but no longer belong to the first line of drugs. The recall of ' nimesulide granules ' will reduce the short-term performance of the Canchi pharmaceutical industry and not rule out the use of the drug in the long term. "said one industry analyst.　　Canchi Pharmaceutical Prospectus said, Rui Zhi Qing in 2007, 2008, 2009 sales of gross profit accounted for the same period sales of gross profit of 72.89%, 84.67% and 89.54% respectively, Rui Zhi Qing's production and sales situation basically determines the company's income and profitability level. Stimulated by the news, today, the two-tier market, the unit low drive low, the plate fell off several times.　　The end of the closing price of 60.49 yuan, tumbled 8.49%, the turnover rate of 38.15%, the daily turnover of several times, up to 572 million yuan. Related news Canchi the prospect of the pharmaceutical industry a lot of pharmacy under the shelf nimesulide